RDHL REDHILL BIOPHARMA LTD
FollowSPONSORED ADR (ADR), issuer CIK 1553846
Filings received so far for Q3 2026: 1 13F filer report a position in RDHL shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Raday Gileadofficer (Chief Operating Officer) | 2026-10-01 | -14,310,000 S | $0.0001 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 287 | $138 | <0.01% | -6,670 | 13F-HRTimeline |
Events
Raday Gilead sold 14,310,000 RDHL shares on 2026-10-01, Form 4 filed 2026-10-06. 0001178913-26-004715
Accepted , ingested